• Biotech in Flanders - A Stunning Story: A new book reveals the secrets behind the success of the Flemish life sciences biotech industry

    Monday November 13th 2023

  • myNEO evolves into myNEO Therapeutics to reflect its new strategy to develop off the shelf cancer vaccine immunotherapeutics

    Wednesday October 25th 2023

  • Biocartis honors Breast Cancer Awareness Month with launch of Breast Cancer Portfolio

    Monday October 16th 2023

  • Agomab raises $100 million Series C to advance fibrosis-focused pipeline

    Wednesday October 11th 2023

  • SwiftPharma launches ODIN.AI: A groundbreaking AI-augmented antibody discovery platform

    Monday October 9th 2023

  • Exploring 40 years of biotech excellence

    Wednesday October 4th 2023

  • SwiftPharma and Medace sign strategic collaboration agreement for biomanufacturing and purification of promising medicinal proteins.

    Wednesday September 27th 2023

  • The QbD Group launches its new Business & Communications division

    Monday September 18th 2023

  • Your news here?

  • SwiftPharma and the Population Council Pursue Agreement to Manufacture Griffithsin Needed for the Development of a Fast-Dissolving Insert for Protection Against HIV

    Friday September 8th 2023

  • The QbD Group acquires life sciences consultancy Azierta to reinforce its global vigilance services and expand its presence in Spain

    Tuesday September 5th 2023

  • SwiftPharma and AntoXa Corporation sign exclusive collaboration agreement to support the development and commercialization of a plant-made antibody against ricin exposure

    Friday September 1st 2023


Strategic Partners